Drug Shortage Report for L-ARGININE HYDROCHLORIDE INJECTION

Last updated on 2023-01-19 History
Report ID 168545
Drug Identification Number 00399736
Brand name L-ARGININE HYDROCHLORIDE INJECTION
Common or Proper name L-ARGININE HCL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ARGININE HYDROCHLORIDE
Strength(s) 250MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 30ML 1LIVI
ATC code V04CD
ATC description OTHER DIAGNOSTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-02
Estimated end date 2022-12-27
Actual end date 2023-01-18
Shortage status Resolved
Updated date 2023-01-19
Company comments Baxter item : 1060 Product is available on allocation based on 90% of historical volumes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2023-01-19 French Compare
v23 2023-01-19 English Compare
v22 2022-12-16 French Compare
v21 2022-12-16 English Compare
v20 2022-12-15 French Compare
v19 2022-12-15 English Compare
v18 2022-12-15 French Compare
v17 2022-12-15 French Compare
v16 2022-12-15 English Compare
v15 2022-12-15 French Compare
v14 2022-12-15 English Compare
v13 2022-11-29 French Compare
v12 2022-11-29 English Compare
v11 2022-11-29 French Compare
v10 2022-11-29 English Compare
v9 2022-11-02 French Compare
v8 2022-11-02 English Compare
v7 2022-11-01 French Compare
v6 2022-11-01 English Compare
v5 2022-09-03 English Compare

Showing 1 to 20 of 24